Quipt Home Medical confirms receipt of unsolicited acquisition proposal

Quipt Home Medical (QIPT) announced that it has received an unsolicited non-binding and conditional and indicative proposal from Forager Capital Management to acquire 100% of the Company’s issued and outstanding common shares at a price of $3.10 per common share. It is the Company’s policy not to comment on unsolicited offers and is confirming its receipt of the Non-Binding Proposal only because Forager has made it public. As previously disclosed, the Company entered into a Non-Disclosure and Standstill Agreement, dated February 1, 2025, with Forager Fund and FCM. The Agreement provides that Forager, and other representatives of Forager will, for a period of six months after the date of the Agreement, not directly or indirectly acquire, by purchase or otherwise, any equity securities or assets of Quipt, or rights or options to acquire interests in any of Quipt’s equity securities or assets without the prior advance approval in writing by the Board of Directors of the Company. The Agreement also provides for customary terms related to the non-disclosure and use of confidential information of Quipt. The Board did not provide Forager with any prior written approval for a waiver of the confidentiality provision or the Standstill provision relating to the issuance of the Non-Binding Proposal.